Abstract
PURPOSE: The aim of this study was to evaluate 5-year and 10-year disease-free survival, urinary dysfunction, and sexual activity after nerve-sparing radical surgery, including lumboaortic lymphadenectomy for rectosigmoid cancer. METHODS: Since 1980 to 1992, 302 consecutive patients affected with rectal (188) or sigmoid (114) resectable cancer underwent radical surgery. Lumboaortic lymphadenectomy was routinely performed and total mesorectal dissection was always accomplished in rectal cancer. Splanchnic nerves, superior hypogastric plexus, hypogastric nerves, and sacral parasympathetic nerves were sought, identified, and preserved or, when necessary, unilaterally sacrificed. Fifty-three (17.6 percent) patients were classified Dukes A, 145 (48.0 percent) B, 46 (15.2 percent) C1, and 17 (5.6 percent) C2. Thirtynine (12.9 percent) patients were Dukes D. In 85 rectal cancer patients, tumor was located at the lower third. Eighty-six of 210 Dukes B and C patients were submitted to systemic chemotherapy and/or high-dose pelvic radiotherapy. RESULTS: The actuarial 5-year disease-free survival was 58.5 percent in rectal and 65.7 percent in sigmoid cancer patients, median follow-up time was 47 months. During the follow-up, each patient was interviewed about sexual activity and urinary dysfunction and a questionnaire was filled out. Urinary dysfunction was not frequently observed, while a definitive sexual impotence was reported in 27.6 percent of the patients. The age under 60 years and sphincter-saving surgery were demonstrated as significantly contributing to retaining a satisfactory sexual activity. CONCLUSIONS: Unexpectedly high disease-free survival was observed in the Dukes C2 subgroup. It allows us to hypothesize that lumboaortic lymphadenectomy could remove neoplastic microfoci present at this level in those patients, enhancing surgical chances of cure. The majority of male patients under 60 years old can retain a satisfactory sexual activity after undergoing a nerve-sparing sphincter-saving cancer surgery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Heald RJ. Function-preserving rectal surgery (Letter). Dis Colon Rectum 1991;34:627–9.
Quirke P, Dixon MF, Durdey P, Williams NS. Local recurrence of rectal cancer due to inadequate resection. Lancet 1986;2:996–9.
Gerard A, Buyse M, Nordlinger B,et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Ann Surg 1988;208:606–14.
Stockholm Rectal Cancer Study Group. Short-term preoperative radiotherapy for adenocarcinoma of the rectum. Am J Clin Oncol 1987;10:369–75.
Jones DJ, Zaloudik J, James RD, Haboubi N, Moore M, Schofield PF. Predicting local recurrence of the rectum after preoperative radiotherapy and surgery. Br J Surg 1989;76:1172–5.
Reis Neto JA, Quilici FA, Reis JA Jr. A comparison of nonoperativevs. preoperative radiotherapy in rectal carcinoma: a 10-year randomized trial. Dis Colon Rectum 1989;32:702–10.
Zybina MA, Nabatich NN. Results of combination treatment for rectal cancer. Vestn Khir 1975;114:67–70.
Dedkov IP, Zybina MA. Intensive preoperative gammatherapy in combined treatment of cancer of the rectum. Am J Proctol 1976;7:43–7.
Simbertseva LP, Sneshko LL, Smirnov NM. Results of intensive combined therapy for cancer of the rectum. Vop Onkol 1975;21:7–12.
Enker WE. Potency, cure, and local control in the operative treatment of rectal cancer. Arch Surg 1992;127:1396–1402.
Hojo F, Sawada T, Moriya Y. An analysis of survival and voiding, sexual function after wide iliopelvic lymphadenectomy in patients with carcinoma of the rectum, compared with conventional lymphadenectomy. Dis Colon Rectum 1989;32:128–33.
Enker WE, Meilweil ML, Hertz RE,et al. En bloc pelvic lymphadenectomy and sphincter preservation in the surgical management of rectal cancer. Ann Surg 1985;203:426–33.
Moriya Y, Hojo K, Sawada T, Koyama Y. Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 1989;32:307–15.
Cavaliere R, Tedesco M, Giannarelli D,et al. Radical surgery in rectal cancer patients: what does it mean today? J Surg Oncol 1991;2(Suppl):24–31.
Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:323–32.
Gabriel WB, Dukes CE, Bussey HJ. Lymphatic spread in cancer of the rectum. Br J Surg 1935;23:395–413.
Glass RE, Ritchie JK, Thompson HR, Mann CV. The results of surgical treatment of cancer of the rectum by radical resection and extended abdomino-iliac lymphadenectomy. Br J Surg 1985;72:599–601.
Kirkegaard P, Hjortrup A, Sanders S. Bladder dysfunction after low anterior resection for mid-rectal cancer. Am J Surg 1981;141:266–8.
Kinn A-C, Öhman U. Bladder and sexual function after surgery for rectal cancer. Dis Colon Rectum 1986;29:43–8.
Danzi M, Ferulano GP, Abate S, Califano G. Male sexual function after abdominoperineal resection for rectal cancer. Dis Colon Rectum 1983;26:665–8.
Koukouras D, Spiliotis J, Scopa D,et al. Radical consequence in the sexuality of male patients operated for colorectal carcinoma. Eur J Surg Oncol 1991;17:285–8.
Williams JT, Slack WW. A prospective study of sexual function after major colorectal surgery. Br J Surg 1980;67:772–4.
Author information
Authors and Affiliations
About this article
Cite this article
Cosimelli, M., Mannella, E., Giannarelli, D. et al. Nerve-sparing surgery in 302 resectable rectosigmoid cancer patients: Genitourinary morbidity and 10-year survival. Dis Colon Rectum 37 (Suppl 2), S42–S46 (1994). https://doi.org/10.1007/BF02048430
Issue Date:
DOI: https://doi.org/10.1007/BF02048430